HEALTH TECHNOLOGY

Atlas Healthcare Partners and MedAxiom Collaborate to Announce a Next-Gen Cardiovascular ASC Solution

Atlas Healthcare Partners | June 29, 2022

Atlas Healthcare

An industry first cardiovascular-focused ambulatory surgery center (ASC) business has been formed by Atlas Healthcare Partners and MedAxiom. Atlas Healthcare Partners specializes in creating and operating ambulatory surgery centers (ASCs). By increasing access to top-notch, patient-centered heart care in ASCs, Atlas and MedAxiom will improve cardiovascular care as a whole.

With its health system and physician partners, Atlas, the fastest-growing firm in the ASC sector, has a highly integrated strategy that focuses on coordinating doctors and ASCs with the health system's delivery network and plan.

"We're very excited about the opportunity to partner with MedAxiom. MedAxiom has an excellent national reputation as the cardiovascular performance management leader. Together, we will bring a new level of cardiovascular ASC expertise and experience to health systems and physicians throughout the country."

Aric Burke, Atlas CEO

MedAxiom connects cardiovascular programs, leaders, and industry partners to accomplish the Quadruple Aim of high-quality outcomes, lower costs, improved patient experience, and high physician satisfaction. MedAxiom is the pioneer in cardiovascular operational excellence and performance improvement. Through the integration of technology, innovation, and care delivery, MedAxiom is reshaping the future of cardiovascular care.

"Our ambition to enhance cardiovascular care and improve heart health demands creative tactics and solid relationships. Atlas is a renowned leader and expert in outpatient care with a clear line of vision towards the development of ASC service lines. Health systems and physicians wishing to enter the outpatient treatment market now have a solution thanks to the combination of Atlas' significant ASC experience and MedAxiom's cardiovascular-specific knowledge."

Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom
 

Spotlight

Manatt Health, the healthcare division of Manatt, Phelps & Philips, LLP, is a fully-integrated, multidisciplinary legal, regulatory, advocacy and strategic business advisory healthcare practice. Manatt Health’s extensive experience spans the major issues re-inventing healthcare, including Medicaid re-design and innovation; payment and delivery system transformation; health IT strategy; health reform implementation; healthcare mergers and acquisitions; regulatory compliance; privacy and security; corporate governance and restructuring; pharmaceutical market access, coverage and reimbursement; and game-changing litigation shaping emerging law.

Spotlight

Manatt Health, the healthcare division of Manatt, Phelps & Philips, LLP, is a fully-integrated, multidisciplinary legal, regulatory, advocacy and strategic business advisory healthcare practice. Manatt Health’s extensive experience spans the major issues re-inventing healthcare, including Medicaid re-design and innovation; payment and delivery system transformation; health IT strategy; health reform implementation; healthcare mergers and acquisitions; regulatory compliance; privacy and security; corporate governance and restructuring; pharmaceutical market access, coverage and reimbursement; and game-changing litigation shaping emerging law.

Related News

FUTURE OF HEALTHCARE

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Anumana, Inc. | July 14, 2022

Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial intelligence powered software solutions that will detect hidden cardiovascular conditions. The collaboration will drive development and delivery of electrocardiogram (ECG) AI algorithms to help physicians accelerate detection and intervention for patients with previously undetected life-threatening heart disease. The ECG AI algorithm is still in development and not yet FDA authorized for commercial clinical use. The collaboration will support Anumana’s efforts to implement AI-enabled diagnostic software that can detect signals from ECGs that humans cannot interpret. The collaboration will initially focus on cardiovascular diseases. Working with its expert partners from Mayo Clinic, Anumana will deploy novel solutions that use AI to analyze an ECG, a widely available, painless test that records the heart’s electrical signals to identify undiagnosed left ventricular dysfunction, or a weak heart pump, which can lead to heart failure. The AI will also screen for atherosclerotic cardiovascular disease, which can lead to heart attack and stroke. In addition, an evidence-based, digital point-of-care solution will be developed to guide in optimizing guideline-directed medical therapies with the aim to lower risk for potentially avoidable hospitalizations and cardiovascular death. “Anumana technology is designed to help physicians identify patients who are at maximum risk of heart failure, long before they develop symptoms. Bringing together premier global organizations will allow us to expand access to best-in-class, AI-powered digital tools to benefit patients through earlier detection and intervention, when and where health care providers need it most.” Murali Aravamudan, CEO of Anumana “Many heart diseases develop for years before signs and symptoms appear, but the first event may be life threatening,” said Paul Friedman, M.D., Chair of the Department of Cardiovascular Medicine at Mayo Clinic and Chair of Anumana’s Mayo Clinic Board of Advisors. “AI enables us to uncover hidden signals our bodies transmit to detect otherwise occult heart diseases, potentially years before symptoms appear. This collaboration has the potential to transform the use of a ubiquitous inexpensive test, the ECG, with the aim of democratizing disease detection and helping medical care teams to proactively manage heart disease ahead of time and prevent some clinical events from ever happening.” “Cardiovascular disease is a widespread and multifactorial disease and, in order to mitigate its impact, we must look beyond therapeutic innovation and reimagine how we approach cardiovascular care,” said Victor Bulto, President, Novartis Innovative Medicines US. "Novartis is proud to collaborate with Anumana on innovative and data-driven solutions to better predict the risk of life-threatening heart disease, further driving forward our commitment to improving patient experiences and population health outcomes in this patient population.” The Mayo Clinic Cardiology team, led by Dr. Friedman, pioneered the application of AI in cardiology and developed several algorithms based on millions of ECGs, including a low ejection fraction algorithm that received FDA Breakthrough Device Designation in 2019 and Emergency Use Authorization for COVID-19 in 2020. Further validating the technology, a recent study presented by Mayo Clinic used a modified version of Anumana’s 12-lead ECG algorithm to detect left ventricular dysfunction with single-lead ECGs in smartwatches. These algorithms are licensed to Anumana for development of clinical solutions and have been validated by over 30 peer-reviewed publications, including a first of its kind prospective clinical impact study on low ventricular ejection fraction that was published in Nature Medicine in 2021. These software solutions are currently in development with each algorithm as a candidate for marketing authorization through an FDA De Novo request. About Anumana Anumana, an AI-driven health technology company and a portfolio company of nference and Mayo Clinic Platform, is harnessing industry-leading AI and translational science to decode the electrocardiogram as never before – as a deep predictive tool and biomarker of disease – empowering care providers to help patients early. Anumana algorithms have been developed, trained, and validated using clinical data from Mayo Clinic and are undergoing rigorous clinical trial validation. Anumana is developing AI-enabled ECG algorithms for real-world physician use, integrating point-of-care applications into existing workflows, thereby reducing costs and enhancing quality of life. Anumana’s AI-enabled tools can diagnose hidden conditions earlier than ever before. Anumana’s algorithms are investigational medical devices and have not yet received regulatory approval or clearance.

Read More

HEALTH TECHNOLOGY

Liberty HomeCare and Hospice Announces Axxess as New Healthcare Technology Partner

Microba Life Sciences Limited | May 26, 2022

On May 25th, premier palliative care provider Liberty HomeCare and Hospice announced a partership with healthcare technology solutions firm, Axxess. Liberty aims to enhance its clinician experience by automating documentation and other processes. The organization chose Axxess in a bid to improve employee retention and centralize its billing process. "I didn't expect to make a software transition again in my career, but when we vetted Axxess it was an easy decision. The service and communication they have provided has been above and beyond. The clinical team and the billing and financial leaders have high regard for Axxess. We have already seen revenue growth in locations using Axxess, and more of the branches are asking to be in the next implementation wave." Holly MacDonald, president of Liberty HomeCare and Hospice Liberty serves to communities through its 30 locations in Virginia, North Carolina, and South Carolina. The organization has been delivering quality hospice, home care, and palliative care. It also rolled out the first phase of the Axxess platform implementation, and plans to unveil it across its other locations. John Olajide, founder and CEO of Axxess, added, "The partnership between Liberty and Axxess is a natural fit. Holly and the Liberty team made it clear that they wanted to work with a company that would be responsive and innovative so they can efficiently and effectively run their enterprise operations. Axxess is committed to working with our clients to deliver what they need, and we have the global presence and resources to do that every day." Axxess is an innovator in healthcare technology and is trusted by more than 9,000 firms in the healthcare industry. The company is well known for its range of cutting-edge software that is currently used to serve over 3 million patients globally. MacDonald further commented, "For our clinicians, the Axxess Certification Program is going to create so many efficiencies. It will give us a standard way to get our staff properly trained. With an organization of our size, we needed a way to uniformly train our staff. When we saw this program, we immediately knew this was the solution we needed."

Read More

HEALTH TECHNOLOGY

Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare

Google Cloud | July 18, 2022

Northwell Health, New York State's largest health care provider and private employer, and Google Cloud announced a collaboration to improve patient care, clinician experiences, and to help the health and hospital network operate more efficiently. The new alliance will be paramount in Northwell's effort to transform digital and connected experiences with the cloud and artificial intelligence (AI) to increase the efficiency of care and allow the health system more opportunities to better deliver equitable care in the communities it serves. Leveraging Google's advanced technology will give Northwell the ability to enhance experiences in digital scheduling, automate payer interactions and provide intelligent summarizations of medical information. In addition, Northwell will leverage Google Cloud's AI and machine learning (ML) capabilities for predictive insights to help with capacity planning and scheduling, and to identify risk indicators to help with early interventions. "Digital transformation is critical to our long-term goals of further advancing clinical excellence in our health system," said Michael Dowling, president and CEO, Northwell Health. "This partnership will help us deliver personalized experiences by safely and privately harnessing customers' data to enhance care, well-being, and equity in care for our patients." As part of this partnership, Northwell Health will leverage Google Cloud as its preferred cloud platform for infrastructure modernization, and to build an interoperable data platform with AI and ML capabilities. This includes contextual recommendations that equip nurses and clinicians with decision making support that goes beyond summarizing the information from different records, building relationships between the information to help support the right actions at the right time. "People want the same kind of seamless experiences and access to their healthcare that they have in other areas of their life, and healthcare providers need to meet these demands while also running the organization more efficiently. Northwell Health is taking the lead on innovation and interoperability to transform health and wellness for millions of New Yorkers." Joe Miles, managing director, Global Healthcare & Life Sciences Solutions for Google Cloud Privacy and security will be of the utmost importance in all aspects of this digital transformation. Through the implementation of Google Cloud's reliable infrastructure along with Northwell Health's layers of security, privacy controls and processes, the access and use of patient data will be appropriately protected. About Northwell Health Northwell Health is New York State's largest health care provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 80,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. About Google Cloud Google Cloud accelerates every organization's ability to digitally transform its business. We deliver enterprise-grade solutions that leverage Google's cutting-edge technology – all on the cleanest cloud in the industry. Customers in more than 200 countries and territories turn to Google Cloud as their trusted partner to enable growth and solve their most critical business problems.

Read More